期刊文献+

表皮生长因子介导的基因转移载体蛋白的制备 被引量:3

Expression and Purification of Gene Transfer Vehicle Mediated by Epidermal Growth Factor Receptor
下载PDF
导出
摘要 目的制备一种表皮生长因子(EGF)受体介导的、完全非病毒基因转移载体。方法通过PCR分别扩增出人类组蛋白第一功能域(H1)基因的编码序列和EGF的受体结合结构域(C环)基因的编码序列:将它们以EcoRⅠ位点连接后作为模板,PCR扩增出融合蛋白H1EGFc的基因。在对此融合基因进行克隆、测序之后,构建原核表达载体PLYI-H1EGFc,并转化大肠杆菌DH5α进行诱导表达。将表达出的融合蛋白利用SDS-PAGE电泳凝胶切割法进行纯化。结果表达出的目的蛋白与设计的融合蛋白分子量相符;经SDS-PAGE扫描,纯化后的目的蛋白纯度达94.02%。结论表达并纯化了融合蛋白H1EGFc。 Objective To create a gene transfer vehicle for targeting gene therapy of cancer with epidermal growth factor receptor overexpressing.Methods Encoding sequences of the first domain of histone gene (H1)and EGF C-loop (EGFc)were obtained by PCR amplification.These two DNA fragments were ligated by EcoRⅠsite,and cloned and sequenced.E.coli expression vector of the fusion gene was then constructed.The fusion protein H1EGFc was purified by specific band isolation from SDS-PAGE.Results The molecular weight of purified protein was consistent with the designed request.Its purity reached94.02%.Conclusion A fusion protein H1EGFc was expressed and purified.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2002年第4期381-384,共4页 Acta Academiae Medicinae Sinicae
基金 国家973肿瘤项目基金(G1998051214)资助~~
关键词 表皮生长因子受体 靶向基因载体 恶性肿瘤 基因治疗 PCR epidermal factor growth target gene vehicle
  • 相关文献

参考文献2

共引文献14

同被引文献30

  • 1甄永苏.抗肿瘤导向药物研究的现状与展望[J].药学学报,1994,29(1):1-8. 被引量:21
  • 2苗庆芳,尚伯杨,欧阳志钢,刘小云,甄永苏.单域抗体与力达霉素的基因工程强化融合蛋白VL-LDP-AE的制备及其抗肿瘤作用[J].中国科学(C辑),2007,37(2):143-151. 被引量:6
  • 3Herbst RS. Review of epidermal gTowth factor receptor biology [J]. Int J Radiat Oncol Biol Phys, 2004,59(2 Suppl.) :21-26.
  • 4Rowinsky EK. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors [J]. Annu Rev Med, 2004,55 : 433-457.
  • 5Woodbum JR. The epidermal growth factor receptor and its inhibition in cancer therapy [J]. Pharmacol Ther, 1999,82 (2-3) :241-250.
  • 6Shaw JP, Akiyoshi DE, Arrigo DA, et al. Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins [J]. J Biol Chem 1991, 266 (31):21118-21124.
  • 7Shao RG, Zhen YS. Enediyne anticancer antibiotic lidamycin: chemistry, biology and pharmacology, [J]. Antieancer Agents Med Chem, 2008,8(2) : 123-131.
  • 8Wakeling AE, Guy SP, Woodburn JR, et al. ZD1839 (Iressa) : an orally active inhibitor of EGF signaling with potential for cancer therapy [J]. Cancer Res, 2002,62(20) :5749-5754.
  • 9Mori T. Cancer-specific ligands identified from screening of peptide-display libraries [J]. Curr Pharm Des. 2004, 10(19): 2335-2343.
  • 10Landon LA, Zou J, Dwutscher SL. Is phage display technology on target for developing peptide-based cancer drugs? [J]. Curr Drug Discov Technol, 2004,1 (2):113-132.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部